| Leo Pharma Jobs Profile
This profile is a brief introduction for people seeking employment in pharmaceutical graduate jobs, pharmaceutical nurse advisors, pharmaceutical sales jobs, pharmaceutical training jobs, pharmaceutical sales management jobs, pharmaceutical marketing jobs, pharmaceutical executive jobs, or pharmaceutical clinical research associates who may be considering working for Leo Pharma. 
LEO Pharma Mission Statement LEO Pharma is committed to the research, development and marketing of safe and effective prescription medicines, thereby supporting the LEO Foundation's contributions to medical science, chemistry and pharmacy. Part of the LEO group of companies, the parent company of which is LEO Pharma is located in Denmark and is owned by the LEO Foundation. LEO Pharma is primarily a sales and marketing company although we also have a large medical department which carries out clinical studies on behalf of the group.
LEO specialises in the research and development of prescription medicines. In the UK, LEO Pharma is the leading dermatological company in the prescription medicine market. LEO is one of the largest primary producers of heparin in the world, isolating it solely from porcine mucosa. |
Dermatology The main strategic area of LEO is dermatology and, in the UK, we are the leading dermatological company in the prescription medicine market. Our position in this area has been driven by our research on vitamin D analogues in which we are a world leader. Critical care Other strategic therapeutic areas include renal bone disease, also resulting from vitamin D research, and anticoagulation, in particular heparin, both unfractionated and low molecular weight products. Other products Other products include Burinex, Centyl K, Fucithalmic and Selexid. 
|  |  |  | Nikki Leo Pharma Account Manager 01494 818032 (Mon to Fri 0830 to 1800 hours) nikki@zenopa.com
|
|

Current Jobs
Key Account Executive - Critical Care Location: Scotland
Key Account Executive - Critical Care Location: South West of England
Sales Executive Location: Sheffield
Key Account Exeutive - Critical Care Location: North, West London and Herts
News
Leo Pharma announces 'weapon' against psoriasis management Leo Pharma has unveiled its new "weapon" in its ongoing campaign to improve the management of psoriasis and treatment outcomes for patients with the condition.
Leo Pharma psoriasis drug approved in Europe Leo Pharma has announced its compound for the treatment of scalp psoriasis has been approved for use in Europe.
Leo Pharma reports 'good year' in 2007 Leo Pharma has said that 2007 was a good year for the company, which achieved an increase in turnover it believed to be satisfactory and ahead of previous estimates.
LEO Pharma launches blood clot prevention drug LEO Pharma has announced the launch of ATryn (antithrombin alfa), a compound used to prevent blood clots in patients unable to produce sufficient quantities or quality of antithrombin - a vital protei...
Leo Pharma submits MAA for scalp psoriasis gel Leo Pharma has this week announced the submission of a marketing authorisation application (MAA) for Daivobet scalp gel to the health authorities in 16 European countries and the US.
|